What is the P/E ratio of Trident Clinical Research India Pvt. . (Amalgamated)?

The latest standalone P/E ratio of Trident Clinical Research India Pvt. . (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Trident Clinical Research India Pvt. . (Amalgamated)?

The latest standalone P/B ratio of Trident Clinical Research India Pvt. . (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Trident Clinical Research India Pvt. . (Amalgamated)?

The 52-week high of Trident Clinical Research India Pvt. . (Amalgamated) is Rs. and the 52-week low is Rs. .

Trident Clinical Research India Pvt. Ltd. (Amalgamated) - Stock Valuation and Financial Performance

Name: Trident Clinical Research India Pvt. . (Amalgamated)
Brand: Trident Clinical Research India Pvt. . (Amalgamated)

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Trident Clinical

Based on:

Data

M-Cap below 100cr DeciZen not available

Trident Clinical Research India Pvt. Ltd. (Amalgamated) stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

0 Cr.

52-wk low:

52-wk high:

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Trident Clinical:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	TTM
ROCE % ⓘ	13.6%	14.2%	14.2%	36.8%	8.2%	7%	8.8%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	1.4	1.7	2	2.8	1.8	1.8	1.6	2
Sales YoY Gr.	-	20.4%	15.8%	40.9%	-37.3%	0%	-8.6%	-
Adj EPS ⓘ	18.9	21.4	27.6	86.5	23.9	21.7	29.5	0
YoY Gr.	-	13%	29.1%	213.7%	-72.3%	-9.4%	36.1%	-
BVPS (₹) ⓘ	139.4	161	192.1	278.6	302	322.1	349.2	0
Adj Net Profit ⓘ	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0
Cash Flow from Ops. ⓘ	0	0	0	0	0	0.5	0.3	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-1.3%	-16.9%	-8.6%
Adj EPS ⓘ	NA	6.7%	-30.1%	36.1%
BVPSⓘ	NA	16.7%	7.8%	8.4%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	TTM
Return on Equity % ⓘ	13.5	14.2	14.2	36.8	8.2	7	8.8	0
Op. Profit Mgn % ⓘ	20.8	12.7	19.4	40.4	23.3	22.5	28.7	NAN
Net Profit Mgn % ⓘ	11.7	11	10.1	22.4	9.9	8.9	13.3	0
Debt to Equity ⓘ	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	0	93	120	172	299	219	227	0
Cash Conv. Cycle ⓘ	0	-38	-347	-609	-813	144	145	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Trident Clinical Research India Pvt. Ltd. (Amalgamated)

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	1.6	-
BVPS (₹.) ⓘ	0	-
Reserves (₹ Cr.) ⓘ	2	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	- / -
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	0
Face Value (₹)	10
Industry PE ⓘ	48.8

Management X-Ray of Trident Clinical:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Trident Clinical

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Trident Clinical

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15
Sales	1.42	1.71	1.98	2.79	1.75	1.75	1.60
Operating Expenses ⓘ	1.16	1.50	1.60	1.66	1.34	1.37	1.16
Manufacturing Costs	0.01	0	0	0	0	0.06	0.06
Material Costs	0	0	0	0	0	0	0
Employee Cost	0.48	0	0	0	0	0.52	0.32
Other Costs ⓘ	0.67	1.50	1.60	1.66	1.34	0.80	0.79
Operating Profit ⓘ	0.26	0.22	0.38	1.13	0.41	0.38	0.43
Operating Profit Margin (%)	18.6%	12.7%	19.3%	40.4%	23.3%	21.5%	27.2%
Other Income ⓘ	0	0	0	0	0	0	0.01
Interest ⓘ	0	0	0	0	0	0	0
Depreciation ⓘ	0.07	0.03	0.07	0.24	0.15	0.14	0.14
Exceptional Items ⓘ	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.20	0.19	0.32	0.88	0.25	0.23	0.30
Tax ⓘ	0.05	0	0.12	0.26	0.08	0.09	0.10
Profit After Tax	0.14	0.19	0.20	0.62	0.17	0.14	0.20
PAT Margin (%)	10.2%	11.0%	10.0%	22.4%	9.7%	8.3%	12.3%
Adjusted EPS (₹)	16.4	21.4	27.6	86.5	23.5	20.0	27.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15
Equity and Liabilities
Shareholders Fund	1.23	1.42	1.39	2.01	2.18	2.32	2.52
Share Capital ⓘ	0.09	0.09	0.07	0.07	0.07	0.07	0.07
Reserves ⓘ	1.15	1.33	1.31	1.94	2.11	2.25	2.45
Minority Interest	0	0	0	0	0	0	0
Debt	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0
Trade Payables	0	0.02	0.14	0.83	0.04	0.03	0.02
Others Liabilities ⓘ	0.19	0.39	0.34	0.44	0.07	0.04	0.13
Total Liabilities ⓘ	1.43	1.83	1.87	3.29	2.29	2.40	2.68
Fixed Assets
Gross Block	0.23	0.26	0.57	0.90	1.01	1.08	1.18
Accumulated Depreciation	0.14	0.17	0.15	0.24	0.33	0.47	0.61
Net Fixed Assetsⓘ	0.09	0.08	0.42	0.66	0.68	0.61	0.58
CWIP ⓘ	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0
Inventories	0	0	0	0	0	0	0
Trade Receivables	0.47	0.31	0.68	1.20	0.89	0.67	0.78
Cash Equivalents ⓘ	0.83	1.37	0.52	0.92	0.45	0.86	1.05
Others Assetsⓘ	0.04	0.06	0.25	0.50	0.28	0.27	0.28
Total Assets ⓘ	1.43	1.83	1.87	3.29	2.29	2.40	2.68

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15
Cash Flow From Operating Activity ⓘ	0.48	0.29
PBT ⓘ	0.23	0.31
Adjustment ⓘ	0.14	0.18
Changes in Working Capital ⓘ	0.19	-0.07
Tax Paid ⓘ	-0.09	-0.11
Cash Flow From Investing Activity ⓘ	-0.07	-0.10
Capex	-0.07	-0.11
Net Investments	0	0
Others ⓘ	0	0
Cash Flow From Financing Activityⓘ	0	0
Net Proceeds from Shares ⓘ	0	0
Net Proceeds from Borrowing ⓘ	0	0
Interest Paid ⓘ	0	0
Dividend Paid ⓘ	0	0
Others ⓘ	0	0
Net Cash Flow ⓘ	0.41	0.19

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15
Ratios
ROE (%)	11.77	14.22	14.18	36.75	8.09	6.42	8.09
ROCE (%)	16.02	14.22	22.65	51.99	11.82	10.44	12.44
Asset Turnover Ratio	1	1.05	1.07	1.08	0.63	0.75	0.63
PAT to CFO Conversion(x)	0	2.53	1.45	0	0	0	0
Working Capital Days
Receivable Days	120	83	92	123	218	162	165
Inventory Days	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0

Trident Clinical Research India Pvt. Ltd. (Amalgamated) Stock News

Trident Clinical Research India Pvt. Ltd. (Amalgamated) FAQs

What is the share price of Trident Clinical?

Company share prices are keep on changing according to the market conditions. The closing price of Trident Clinical on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Trident Clinical?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Trident Clinical stood at ₹0.00.